andrew huberman semaglutide on Retatrutide: What He Said and What the Data Shows Semaglutide just got FDA-approved for

Patients with a history of certain medical conditions such as cardiovascular disease may be a better candidate for Tirzepatide

Non-steroidal anti-inflammatory drugs (NSAIDs), statins, glucocorticoids and monoclonal antibodies (e.g., targeting IL-6, TNF-, IL-12/23) have been reported to show moderate anti-depressant capacity in patients with somatic disorders (i.e., rheumatoid arthritis, psoriasis) who also had comorbid symptoms of depression [194, 195]

Clinical review 94: what's in a name

Medicare Part D cannot cover drugs used strictly for weight loss, though a GLP-1 may be covered for a qualifying condition like diabetes